Global Perspectives in Ocular Oncology offers an international platform for leading ocular oncologists and multidisciplinary specialists to highlight worldwide strengths and solutions to the challenges in treating eye cancer.

Global Perspectives in Ocular Oncology   Bhavna Chawla, MD and Mary E. Aronow, MD, Editors   Foreword………………………………………………………………………………………..…………………………………………Arun D. Singh, MD   Introduction…………………………………………………………………………..…….………Bhavna Chawla, MD, Mary E. Aronow, MD   Section 1: Ocular Oncology: A Global Subspecialty 1.       Creation and Leadership of an International Society……………………....…Jerry A. Shields, MD, Victoria M. Cohen, MD   Section 2: Progress through International Initiatives 2.       A Universal Language for Eye Cancer Staging…………………………………………………….…………………....…Tero T. Kivela, MD 3.       International Working Day for Ocular Oncology……………………………………………….………..............…..Paul T. Finger, MD 4.       Specialty Interest Groups with Global Presence………………………....………..…. ………………………………..Jesse L. Berry, MD 5.       International Council of Ophthalmology: Training Future Leaders……………………….………...…….Steffen Heegaard, MD   Section 3: International Research Collaborations 6.       Global Presentation of Retinoblastoma……………………………………………………………………………………..….Didi Fabian, MD 7.       Retinoblastoma Trials……………………………………………………………….………………………………………Maja Beck-Popovic, MD 8.       Children’s Oncology Group Trials.……………………...…………………………………………………..Murali M. Chintagumpala, MD 9.       Uveal Melanoma Trials………………………………………………………………………………………..……….……Sarah E. Coupland, PhD 10.   Primary Vitreoretinal Lymphoma Collaborations…………………………………..………….………………………Anjo Riemens, MD 11.   Radiation Oncology Perspectives: Multi-center Collaborative Trials…………………………….....Ruth A. Kleinerman, PhD 12.   Optimizing Outcomes through Multi-disciplinary Partnerships.……….…………………………….……….Helen Dimaras, PhD 13.   Assessing Research Priorities Worldwide..………………………………………………………………….………………..Tim Murray, MD   Section 4: Challenges in the Delivery of Care Worldwide  14.   Improving Outcomes in Remote Settings…………………………………………………………..……………..………Keith Waddell, MD 15.   Overcoming Limited Resources………………………………………………………………………….……… Duangnate Rojanaporn, MD 16.   Removing Barriers to Compliance……………………………………….……….………….…Rita S. Sitorus, MD, Junyang Zhao, MD 17.   Cultural Aspects of Enucleation………………………..…………………………….…….………………………..…..Ihab Saad Othman, MD             18.   Establishing a Clinical Service……………………………………………………..…..………………………………………..Luiz F. Teixeira, MD Capacity Building & Training……………………………………………………………………….…………….………………Carol L. Shields, MD 19.   Implementing New Chemotherapy Programs………........................ Victoria Vishnevska-Dia, MD, Hayyam Kiratli, MD 20.   Awareness, Advocacy, and the Volunteer Sector…………………………..……….…………………………………………Vinay Jain, MD 21.   Establishing and Maintaining a National Registry…………………………….…………………….………………Annette C. Moll, MD   Section 5: Ocular Oncology Management Pearls: Worldwide Contributions  22.   Intravenous Chemotherapy for Retinoblastoma: A Pediatric Oncology View-point..……………  Ann M. Leahey, MD 23.   Intra-arterial Chemotherapy for Retinoblastoma: Then and Now. Shizenobu Suzuki, MD, Jasmine H. Francis, MD 24.   Intravitreal Chemotherapy for Retinoblastoma: Refinement of the Technique………………… Francis L. Munier, MD 25.   Toxicity Related to Chemotherapy: A Pediatric Oncology Viewpoint……………………………………………Francis Doz, MD 26.   Novel Surgical Techniques for Melanocytic Tumors……………………………………………………….…….Bertil E. Damato, MD                 27.   Novel Therapies for Choroidal Melanoma……………………..……………..………………………..…………………Brian P. Marr, MD 28.   Update: Metastatic Uveal Melanoma…………………….…Sapna Patel, MD, Takami Sato, MD, Richard D. Carvajal, MD 29.   Ocular Toxicity Secondary to Immunotherapy…………………………………………………………………..……Dan S. Gombos, MD 30.   Advanced Surgical Techniques for Ocular Surface Squamous Neoplasia………………………………  Sachin M. Salvi, FRCS 31.   Topical Chemotherapy for Ocular Surface Tumors……………………….……………………………………..……Carol L. Karp, MD 32.   Management of Melanocytic Tumors of the Conjunctiva……………………………………………………Mandeep Sagoo, FRCS                33.   Adjuvant Therapy for Eyelid Tumors……………………………………………………………………………..Gangadhara Sundar, FRCS 34.   Novel Strategies for Advanced Presentations of Periocular Malignancies ………………………………...Bita Esmaeli, MD                  35.   Diagnostic Pearls for Primary Vitreoretinal Lymphoma….…Nida H. Sen, MD, Chi-Chao Chan, MD, Jose Pulido, MD 36.   Intravitreal Chemotherapy for Primary Vitreoretinal Lymphoma………………..Shahar Frenkel, MD, Jacob Pe’er, MD   37.   Advances in Histopathology………………………  Hardeep Muthar, MD, Patricia Chevez Barrios, MD, Ralph Eagle, MD                                                                                               Section 6: Innovations and Technology in Ocular Oncology 38.   The Role of Telemedicine in Ocular Oncology………………………………………………………………..………..Rubens Belfort, MD 39.   Harnessing the Power of Artificial Intelligence…………………………………………………………………………….Zelia Correa, MD 40.   Recruiting Expertise from Crowd Sourcing………………………………………………………………………………Sandra Staffieri, MD 41.   Novel Delivery Methods for Chemotherapy…………………………………………………………………….……   Linn Murphree, MD Developing Animal Models…………………………………………………………………………..…….…….…….Matthew W. Wilson, MD 42.   Precision Medicine in Ocular Oncology……………………………………………………………………………Guillermo Chantada, MD 43.   Genomics: Past, Present and Future………………………………………………………………………………………….Brenda Gallie, MD  44.   Translational Research………………………………………………………………………………Narsing A. Rao, MD, Martine Jager, MD   Section 7: The Future of Ocular Oncology 45.   Perspectives……………………………………………………………………………….Evangelos Gragoudas, MD, Jerry A. Shields, MD                    Web-based Resources  One Retinoblastoma World: http://map.1rbw.org/ Eye Cancer Network: https://www.eyecancercure.com/ Clinic Trials: https://clinicaltrials.gov/

Eye cancers vary in presentation depending upon geographic location and access to healthcare. Global Perspectives in Ocular Oncology offers an international platform for leading ocular oncologists and multidisciplinary specialists to highlight worldwide strengths and solutions to the challenges in treating eye cancer. The goal of the book is to provide a universal view on the management of adult and pediatric tumors affecting the eye and ocular adnexa.  A range of topics pertinent to the global community have been included. Organized into seven distinct sections, this book covers international collaborations and initiatives, technology and innovations, and novel treatment strategies. In addition, it provides a glimpse into the future of the specialty. The emphasis on sharing perspectives as well as the global and multidisciplinary framework of the book are unique to the market. This work will appeal to a variety of audiences including ocular oncologists and ophthalmic subspecialists, oncologists and other specialists, optometrists, geneticists, allied medical professionals, and trainees entering these disciplines.

Offers an international perspective on the varied spectrum of adult and pediatric eye cancersIncludes international and multidisciplinary contributorsBroken up into seven sections and includes a section on technology and innovation